EXPLANATORY STATEMENT
Tariff Concession Instrument No. 0509750
Customs Act 1901
Background
Part XVA of the Customs Act 1901 (the Act) sets out a scheme under which Tariff Concession Orders (TCOs) may be made by the Chief Executive Officer of Customs (the CEO). A lower rate of customs duty applies to goods that are the subject of a TCO.
Under section 269F of the Act, a person may apply to the CEO for a TCO in respect of goods. If the CEO is satisfied that the application is not in respect of goods specified in section 269SJ of the Act, which sets out those goods that cannot be subject to a TCO, the CEO must decide whether the application meets the core criteria.
Section 269C of the Act provides that a TCO application meets the core criteria if, on the day on which the application was lodged, no substitutable goods were produced in Australia in the ordinary course of business. Section 269B of the Act provides that ‘goods produced in Australia’ has the meaning given by section 269D, ‘ordinary course of business’ has the meaning given by section 269E and ‘substitutable goods’ in respect of goods the subject of a TCO application, means goods produced in Australia that are put, or are capable of being put, to a use that corresponds with a use (including a design use) to which the goods the subject of the application can be put.
Subsection 269P(3) of the Act provides that if the CEO is satisfied that a TCO application meets the core criteria, the CEO must make a written order (a TCO) declaring that the goods the subject of the TCO application are goods to which a prescribed item of Schedule 4 to the Customs Tariff Act 1995 (the Tariff) specified in the order applies.
Lipa Pharmaceuticals Ltd applied for a TCO in respect of certain pharmaceutical mixers on 22 July 2005.
Instrument
TCO No 0509750 was made on 07 October 2005. It declares that those certain pharmaceutical mixers are goods to which item 50 of Schedule 4 to the Tariff applies since the CEO was satisfied that no substitutable goods were produced in Australia. The general rate of duty on these goods is 5%. The rate of duty for the goods subject to the TCO is free.
Consultation
Subsection 269K(1) of the Act provides in part that as soon as practicable after accepting a TCO application as a valid application, the CEO must publish a notice in the Gazette which includes an invitation to any person who considers that there are reasons why the TCO should not be made to lodge a submission with the CEO. The CEO did not receive any submissions in response to this invitation.
Commencement
Subsection 269S(1) relevantly provides that a TCO is to be taken to have come into force on the day on which the application for the TCO was lodged. TCO No. 0509750 is taken to have come into force on 22 July 2005.
The TCO does not affect the rights of a person (other than the Commonwealth) as at the date of registration so as to disadvantage that person or impose liabilities on a person (other than the Commonwealth) in respect of anything done or omitted to be done before the date of registration. The rights of importers will be beneficially affected. Under paragraph 126(1)(r) of the Regulations, importers of such goods will be able to apply for a refund of duty on goods imported since the day on which the TCO is taken to have come into force. The TCO does not impose any liabilities on any person.
Overview
The Customs Act 1901, enacted by the Australian Parliament, established a framework for the regulation of imports and exports. It included provisions for Tariff Concession Orders (TCOs), which allow for a lower rate of customs duty on certain goods. The problem this legislation aimed to address was the need for a streamlined process to provide tariff relief on specific goods where no domestic substitutes are produced. This mechanism ensures that businesses can access essential goods at a reduced duty cost, promoting trade and economic efficiency. The Tariff Concession Instrument No. 0509750, made on 7 October 2005, exemplifies this process by granting free duty on certain pharmaceutical mixers, thereby facilitating the import of these goods without incurring the standard 5% customs duty. The instrument was introduced without any submissions opposing its implementation, underscoring its alignment with the legislative intent to efficiently manage tariff concessions.
Scope and Application
The Customs Act 1901, as amended, facilitates the reduction of customs duty on certain goods through Tariff Concession Orders (TCOs). These orders are applicable to specific goods that are not produced in Australia and for which an applicant demonstrates there are no substitutable goods available in the Australian market. The Act applies to any individual or entity that meets the criteria for applying for a TCO, such as Lipa Pharmaceuticals Ltd, which applied for a concession on pharmaceutical mixers. The scope of this legislation is national, as it is administered by the Commonwealth through the Chief Executive Officer of Customs. The application of TCOs is restricted by exclusions detailed in section 269SJ of the Act, which specifies goods that cannot be subject to a TCO. The instrument extends its application through the issuance of specific TCOs as needed, each tailored to particular goods as per the conditions outlined in the Act. The commencement of a TCO is effective from the date the application is lodged, ensuring that any import duties accruing from that date can be subject to a refund as per the Customs Tariff Act 1995.
Key Provisions
The Customs Act 1901, specifically under Part XVA, provides a framework for the Chief Executive Officer of Customs (CEO) to issue Tariff Concession Orders (TCOs). Section 269F allows an individual or entity to apply to the CEO for a TCO for certain goods, provided these goods are not specified in section 269SJ, which lists goods ineligible for TCOs. For a TCO to be considered, the CEO must first be satisfied that the application pertains to goods that are not substitutable and are not produced in Australia in the ordinary course of business (section 269C). Definitions for key terms such as "goods produced in Australia," "ordinary course of business," and "substitutable goods" are provided in sections 269D, 269E, and 269P respectively.
The Act imposes certain obligations on the CEO in processing a TCO application. Once an application is deemed valid, the CEO must publish a notice in the Gazette, inviting any interested parties to submit objections (subsection 269K(1)). Additionally, the CEO is required to make a written order if the application meets the core criteria, as outlined in section 269P(3). In the case of Lipa Pharmaceuticals Ltd’s application for certain pharmaceutical mixers, the CEO issued TCO No. 0509750 on 7 October 2005, after being satisfied that no substitutable goods were produced in Australia, thereby granting a tariff concession on these goods.
Failure to comply with the provisions of the Act can lead to significant legal consequences. While the explanatory statement does not detail specific offences or penalties, breaches of the Customs Act generally could result in both civil and criminal penalties. Civil penalties might include fines, while criminal penalties could involve imprisonment, reflecting the seriousness with which the Australian government treats non-compliance with customs regulations. The exact penalties depend on the nature and severity of the breach, as defined by the broader Customs Act and related legislation.